Combinatorial Study of a Novel Poly (ADP-ribose) Polymerase Inhibitor and an HDAC Inhibitor, SAHA, in Leukemic Cell Lines.

Background: Cancer is a multifactorial disease, which makes it difficult to cure. Since more than one defective cellular component is often involved during oncogenesis, combination therapy is gaining prominence in the field of cancer therapeutics.Objective: The purpose of this study was to investiga...

Descripción completa

Detalles Bibliográficos

Publicado en:	Targeted Oncology Vol. 11; no. 5; pp. 655 - 666
Autores principales:	Hegde, Mahesh, Mantelingu, Kempegowda, Pandey, Monica, Pavankumar, Chottanahalli, Rangappa, Kanchugarakoppal, Raghavan, Sathees, Pavankumar, Chottanahalli S, Rangappa, Kanchugarakoppal S, Raghavan, Sathees C
Formato:	research Journal Article
Publicado:	Springer Nature Oct2016
Acceso en línea:	Ver este registro en EBSCOhost